• World
  • Columnist
  • Commodities
  • WORLD BUSINESS & ECONOMY
  • Executive Knowledge Series
  • Finance
  • Manufacturing
  • Markets
  • Risk & Governance
  • Small Business
  • Technology, Media & Innovation
  • Comments
  • Business AM WebTV
  • Login

Businessamlive
  • FRONTPAGE
  • FINANCE
    • AllAsset ManagementAuditBankingBondBudgetCapital MarketsC&I LeasingCurrencyDealDebt marketForexFund RaisingFundingGovernmentHedge FundsInsuranceInvestmentInvestorInvestor ServicesMergers & AcquistionsMoney marketTreasury BillsMortgagePensionsPersonal financePonziQuantitative EasingshareTaxationTSAWealth Management
      Finance

      Nigeria, Africa remittances on target as Wari, Lycaremit sign partnership

      January 21, 2021

      Companies

      Total Nigeria, Mixta, Valency, list new CPs on FMDQ platform to enhance financial markets development

      January 19, 2021

      Finance

      Amidst N32.22trn public debt, analysts say Nigeria’s external debt service manageable

      January 19, 2021

      Finance

      Stringent regulations, business environment forced Stanbic IBTC out of BDC business

      January 15, 2021

  • MARKETS
  • ECONOMY
    • AllAfricaAgricAirportsAmericaAsiaAustraliaBreakthroughDealEuropeForeign InvestmentsforexGlobal marketGovernanceIMFMiddle EastNECANigeriaOutlookRich listSouth AfricaSport BusinessTradeU.KWest AfricaWorld Economic forum
      Markets

      Nairobi Stock Exchange pushes expansion plans with more listings in 2021, says CEO

      January 23, 2021

      Africa Investment Forum

      Africa’s $60bn losses in illicit capital flows due to multinationals’ tax avoidance, says AfDB Adesina

      January 22, 2021

      Frontpage

      Covid-19 vaccine: Nigeria, 54 others to benefit from African Union’s 270m doses

      January 21, 2021

      Finance

      Nigeria, Africa remittances on target as Wari, Lycaremit sign partnership

      January 21, 2021

  • COMMODITIES
  • ENERGY
    • AllConferenceElectricityOil and GasPowerRenewable
      Companies

      Appeal Court suspends order against shutting of SEPLAT headoffice

      January 23, 2021

      Frontpage

      OPEC welcomes push for electric vehicles, but says fossil fuel remains strong

      January 21, 2021

      National: Governance, Policy & Politics

      Nigeria ramps up domestic LPG consumption above 1MMT, says PPPRA

      January 20, 2021

      Companies

      TIPP Oil, German lubricant maker, targets 2021 Nigeria launch with eco-friendly scheme  

      January 19, 2021

  • TECHNOLOGY
  • MANUFACTURING
  • ANALYSIS
    • Analyst Insight

      CBN meeting and NSE in focus

      January 18, 2021

      Analyst Insight

      Once again, fiscal stimulus takes centre stage

      January 18, 2021

      Analyst Insight

      Organisations must learn from the WhatsApp story  

      January 18, 2021

      Analyst Insight

      Data privacy maturity model in organisations

      January 11, 2021

Frontpage

GlaxoSmithKline, Pfizer megadeal to create world’s medical superpower

December 20, 2018562 views0 comments

 

A global medical superpower that would see combined sales of almost $10 billion will emerge from the planned merger between GlaxoSmithKline (GSK), the British pharmaceutical giant and its United States rival, Pfizer, analysts have pointed out as the story broke Wednesday.

Both GSK and Pfizer are two of the world’s biggest pharmaceutical companies and it has now emerged that the former plans to combine its consumer-health business with Pfizer on a split put at 68 percent to 32 percent equity holdings respectively. Early reports showed investors responded positively with GSK’s shares rising as much as 7.4 percent in London following the announcement.

The companies say they will have a joint market share far exceeding that of rivals such as Johnson & Johnson, Sanofi, and Bayer.

Read Also:

  • Africa opens world’s largest single market (3)

Integrating the two businesses should bring annual savings of £500 million ($633 million) by 2022, with total costs of £1.2 billion, and is expected to be completed by the second half of next year, the companies said.

It marks a continuation of GSK’s dealmaking after it bought the Swiss drugmaker Novartis out of its minority stake in its combined consumer-health business, while earlier this month the company bought the US oncology-focussed firm Tesaro for $5.1 billion.

“In the short-term, teaming up with Pfizer means GSK will become over the counter market leader in pretty much all major geographies around the world, and the partnership should bring significant cost savings too,” said George Salmon, an equity analyst at Hargreaves Lansdown.

“Still though, all deals can be made to look good on paper — the challenge will be delivering smooth execution of those planned savings.”

GSK intends to separate its consumer business from its UK stock-exchange listing within three years of the deal, splitting the company into two separate businesses.

“Ultimately, our goal is to create two exceptional, UK-based global companies, with appropriate capital structures, that are each well positioned to deliver improving returns to shareholders and significant benefits to patients and consumers,” said GSK’s chief executive, Emma Walmsley.

The deal follows on the heels of a news wire report that General Electric’s healthcare business had confidentially filed for an IPO.

Share on Facebook Tweet Email
PreviousU.S., China spar at WTO, blame each other for trade crisis
NextAfrica needs $250 billion to scale up its electricity-Momoh

Leave a comment

- Cancel reply

MARKET DATA

Market Videos

Recent Posts

  • Appeal Court suspends order against shutting of SEPLAT headoffice
  • Eko Atlantic City to utilise local content for economic diversification in Nigeria
  • Nairobi Stock Exchange pushes expansion plans with more listings in 2021, says CEO
  • Africa’s $60bn losses in illicit capital flows due to multinationals’ tax avoidance, says AfDB Adesina
  • Nigeria equities go bearish on selloffs in DangCem, AXA Mansard, UBA

World

Africa

Buhari, Okonjo-Iweala congratulate Adesina over reelection as AfDB President

Europe

EU businesses to cut investments in 2020, says EIB report

America

U.S. increases cost of visa application for Nigerians

Africa

Thatcher-Loving Nigeria Candidate Plans to Overhaul Economy

Africa

AfDB scales up industrialization pace on the continent, delivers improved business access to finance, skills, energy

Frontpage posts

0

CBN reschedules November MPC meeting

Frontpage November 18, 2018

1
2

Oil rises as Saudi Arabia sees OPEC, allies Cooperation beyond 2018

Frontpage January 22, 2018

3

Nigeria bond market bearish as yields fell marginally 5bps

Frontpage February 7, 2018

4

Nigeria tells IMF of intent to have unified, flexible exchange rate

Frontpage April 30, 2020

5

Nigeria’s informal economy accounts for 65% of GDP – IMF

Frontpage August 8, 2017

SUPPORT

  • Photo Gallery
  • Help Centre
  • About Us
  • Accessibility

LEGAL & PRIVACY

  • Terms & Conditions
  • Privacy
  • Cookies
  • Copyright

SERVICES

  • Conferences & Events
  • Analysts Research
  • Advertising Rate
  • Ebooks

TOOLS

  • Portfolio
  • Newsletters
  • News feed
  • Currency Converter

SUBSCRIBE

Join us to get latest updates on business related news.

[mc4wp_form id="3076"]
  • ABOUT US
  • CONTACT US
  • CAREERS
  • TERMS & CONDITIONS
  • PRIVACY POLICY
Copyright 2017. All rights reserved. BusinessAMLive. A Businessnewscorp Member Company.